Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Mitchell | Genex Finalizes Coventry Workers' Comp Services Acquisition
Deal expands industry-leading solutions to boost better claims outcomes and improve lives for injured individuals
Workers' Comp
News Release
Mitchell Genex Finalizes Coventry Workers’ Comp Services Acquisition
San Diego, CA, and Wayne, PA—Mitchell | Genex, a leading provider of cost containment technology, clinical services, and disabilit
Mitchell
Article
Workers’ Comp Data: Healthcare Industry Sector is the Source of the Majority of COVID-19 Claims
Data analysis by Aarthi Thiruvengadam Over the first few months of the COVID-19 pandemic, the workers’ compensation industry has gone thro
Workers' Comp
Article
Therapeutic Alternatives—A Closer Look
Brand name medications are often scrutinized by the workers’ compensation industry for their high cost.
Workers' Comp
Blog
Brand and Generic Medication Trends
Part Two: Evaluating In-Network and Out-of-Network Trends In this final post related to our in-network and out-of-network analysis we
Workers' Comp
Article
Pain Management and Opioid Recovery
Taking a multi-disciplinary approach to ongoing pain management and opioid recovery